Record overview
Status and phase
Status: SUSPENDED
Phase: PHASE2
Sponsor: Hackensack Meridian Health
Condition: Multiple Myeloma
NCT04661137
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Enrollment is paused pending an upcoming amendment